Skip to main content
. 2020 Oct 19;171:112726. doi: 10.1016/j.bios.2020.112726

Fig. 1.

Fig. 1

a) Illustration of the current clinical timeline vs. DETecT Sepsis approach as rapid near-patient testing for disease severity screening based on biomarker levels. Image is created with Biorender.com b) Hyper-inflammatory and Immunosuppressed phase of Sepsis hypothesis c) Proof of feasibility towards establishing evidence-based clinical management approach using n = 40 patient samples.